openPR Logo
Press release

Leading Element Driving Change in the Pipettes, Pipettors, And Accessories Market in 2025: Rising Laboratories Fuel Growth In The Pipettes, Pipettors, And Accessories Market Driver

02-12-2025 02:31 PM CET | Chemicals & Materials

Press release from: The Business Research Company

Pipettes, Pipettors, And Accessories Market Forecast Report

Pipettes, Pipettors, And Accessories Market Forecast Report

The aurora kinase b market size has grown rapidly in recent years. It will grow from $1.14 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate CAGR of 12.1%. The growth in the historic period can be primarily attributed to increasing demand for targeted cancer therapies, a rise in the prevalence of cancer globally, burgeoning investments in precision medicine, growth in the number of clinical trials, and a surge in government funding for cancer research.

Is the future equally promising?
The aurora Kinase B market size is expected to see rapid growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate CAGR of 11.8%. This projected growth can be attributed to rising investments in innovative cancer treatment, the increasing incidence of drug-resistant cancers, expanding research and development initiatives, rising demand for combination therapies, and the escalating prevalence of solid tumors.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20496&type=smp

The rising incidence of cancer is expected to propel the adoption of aurora kinase B in cancer therapies. Cancer is characterized by the uncontrolled growth and spread of abnormal cells and presents a considerable global health concern. With factors such as an aging population, lifestyle changes, environmental exposures, and improved detection methodologies contributing to the rise in cancer incidence, the role of Aurora kinase B in potent cancer therapies gains prominence. Aurora kinase B plays a critical role in mitosis and has been linked to chromosomal instability and cancer progression. Therefore, it often takes center stage in cancer therapies as it is intrinsically involved in tumor cell division.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/aurora-kinase-b-global-market-report

The Aurora Kinase B market witnesses active participation from major companies such as Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, and others. These companies focus on introducing innovative products, like Aurora kinase inhibitors, which specifically target and disrupt crucial processes in cell division.

How is the market structured?
The aurora kinase b market can be segmented by type, application, and end-users. Types include AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, among others. Applications range across Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, etc. End-users comprise hospitals, research institutes, diagnostic laboratories, among others. Subsegments have been further elaborated by considering various stages of clinical trials and treatments using different Aurora kinase inhibitors.

From a geographical standpoint, North America was the largest Aurora Kinase B market region in 2024, and Asia-Pacific is expected to experience the fastest growth in the forecast period. These findings underscore the global appeal and potential of this market.

Browse through more similar reports at The Business Research Company.
Cancer biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Skin Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Pancreatic Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Armed with a robust repository of over 15000+ reports that span across 27 industries and 60+ geographies, this organization has built a solid reputation by offering comprehensive, data-rich research and insights fuelled by 1,500,000 datasets, invaluable in-depth secondary research, and the unique insights drawn from industry leaders. Stay one step ahead in the game with The Business Research Company.

Company Information:
Follow The Business Research Company on
LinkedInhttps://in.linkedin.com/company/the-business-research-company
and YouTubehttps://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ).
Dive deeper into the global market model herehttps://www.thebusinessresearchcompany.com/global-market-model

Reach out to us at info@tbrc.info or call us at:
Americas: +1 3156230293
Asia and Europe: +44 2071930708

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leading Element Driving Change in the Pipettes, Pipettors, And Accessories Market in 2025: Rising Laboratories Fuel Growth In The Pipettes, Pipettors, And Accessories Market Driver here

News-ID: 3865377 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For